F2G and Shionogi have reported that oral olorofim met the [...]

Ananda Pharma has reported positive results from its Phase 1 [...]

Scribe Therapeutics has secured more than $25 million in CIRM [...]

Gesynta Pharma has randomised half of the planned patients in [...]

spliesense-cystic-fibrosis-foundation-spl84-phase2b SpliSense has secured up to $13 million in funding [...]

Poolbeg Pharma has received a decision to grant a European [...]

Confo Therapeutics has presented preclinical data supporting the development of [...]

CERo Therapeutics Holdings, Inc has shared a Phase 1 update [...]

Grifols has launched Fesilty in the USA, making the fibrinogen [...]

The National Institute for Health and Care Excellence has recommended [...]